Delivery Order SPE2DB24D1021-SPE2DB25FEZKC
- Not listed
- The Defense Logistics Agency awarded a $1,337.76 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG in a 30-count package. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.04 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,703.95 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count units) on August 22, 2025, with completion targeted for August 25, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 5-160 mg tablets (30-count) under a firm fixed-price contract valued at $1,129.61. The order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,161.72 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product is a...
- The Defense Logistics Agency has awarded a delivery order valued at $8,336.56 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Amlodipine-Valsartan is a combination antihypertensive medication used in the treatment...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count supply) with a ceiling value of $1,936.74. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to conclude on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $36,196.14 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procedures and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZKCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,424.98 to AmerisourceBergen Drug Corp for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 mg tablets in a 30-count quantity. This competitive, non-set-aside award was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order structure reflects the standardized pharmaceutical procurement methodology utilized by the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill federal medical supply requirements through open competition across multiple therapeutic domains makes it a key vendor within the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 8/7/25 |